Patents by Inventor Howell Franklin Moffett

Howell Franklin Moffett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Recombinant Cell Surface Markers
    Publication number: 20240409610
    Abstract: The present disclosure relates to EGFR-derived polypeptides containing short juxtamembrane sequences, nucleic acids encoding them, and methods of using them to improve cell surface expression of truncated EGFR markers.
    Type: Application
    Filed: June 21, 2024
    Publication date: December 12, 2024
    Applicant: Lyell Immunopharma, Inc.
    Inventors: Howell Franklin Moffett, Marc Joseph Lajoie, Scott Edward Boyken
  • Recombinant cell surface markers
    Patent number: 12054531
    Abstract: The present disclosure relates to EGFR-derived polypeptides containing short juxtamembrane sequences, nucleic acids encoding them, and methods of using them to improve cell surface expression of truncated EGFR markers.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 6, 2024
    Assignee: LYELL IMMUNOPHARMA, INC.
    Inventors: Howell Franklin Moffett, Marc Joseph Lajoie, Scott Edward Boyken
  • Novel Recombinant Cell Surface Markers
    Publication number: 20210309717
    Abstract: The present disclosure relates to EGFR-derived polypeptides containing short juxtamembrane sequences, nucleic acids encoding them, and methods of using them to improve cell surface expression of truncated EGFR markers.
    Type: Application
    Filed: March 19, 2021
    Publication date: October 7, 2021
    Applicant: Lyell Immunopharma, Inc.
    Inventors: Howell Franklin Moffett, Marc Joseph Lajoie, Scott Edward Boyken